TGTX

$36.10+0.39 (+1.11%)

Pre-Market$37.71+1.61 (+4.46%)· Last close May 5

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO